The big data effort in radiation oncology: Data mining or data farming?
Ontology highlight
ABSTRACT:
SUBMITTER: Mayo CS
PROVIDER: S-EPMC5514231 | biostudies-other | 2016 Oct-Dec
REPOSITORIES: biostudies-other
Similar Datasets
Project description:Leveraging Electronic Health Records (EHR) and Oncology Information Systems (OIS) has great potential to generate hypotheses for cancer treatment, since they directly provide medical data on a large scale. In order to gather a significant amount of patients with a high level of clinical details, multicenter studies are necessary. A challenge in creating high quality Big Data studies involving several treatment centers is the lack of semantic interoperability between data sources. We present the ontology we developed to address this issue.Radiation Oncology anatomical and target volumes were categorized in anatomical and treatment planning classes. International delineation guidelines specific to radiation oncology were used for lymph nodes areas and target volumes. Hierarchical classes were created to generate The Radiation Oncology Structures (ROS) Ontology. The ROS was then applied to the data from our institution.Four hundred and seventeen classes were created with a maximum of 14 children classes (average = 5). The ontology was then converted into a Web Ontology Language (.owl) format and made available online on Bioportal and GitHub under an Apache 2.0 License. We extracted all structures delineated in our department since the opening in 2001. 20,758 structures were exported from our "record-and-verify" system, demonstrating a significant heterogeneity within a single center. All structures were matched to the ROS ontology before integration into our clinical data warehouse (CDW).In this study we describe a new ontology, specific to radiation oncology, that reports all anatomical and treatment planning structures that can be delineated. This ontology will be used to integrate dosimetric data in the Assistance Publique-Hôpitaux de Paris CDW that stores data from 6.5 million patients (as of February 2017).
| S-EPMC5774757 | biostudies-literature
Project description:Insight into current scientific applications of Big Data in the precision dairy farming area may help us to understand the inflated expectations around Big Data. The objective of this invited review paper is to give that scientific background and determine whether Big Data has overcome the peak of inflated expectations. A conceptual model was created, and a literature search in Scopus resulted in 1442 scientific peer reviewed papers. After thorough screening on relevance and classification by the authors, 142 papers remained for further analysis. The area of precision dairy farming (with classes in the primary chain (dairy farm, feed, breed, health, food, retail, consumer) and levels for object of interest (animal, farm, network)), the Big Data-V area (with categories on Volume, Velocity, Variety and other V's) and the data analytics area (with categories in analysis methods (supervised learning, unsupervised learning, semi-supervised classification, reinforcement learning) and data characteristics (time-series, streaming, sequence, graph, spatial, multimedia)) were analysed. The animal sublevel, with 83% of the papers, exceeds the farm sublevel and network sublevel. Within the animal sublevel, topics within the dairy farm level prevailed with 58% over the health level (33%). Within the Big Data category, the Volume category was most favoured with 59% of the papers, followed by 37% of papers that included the Variety category. None of the papers included the Velocity category. Supervised learning, representing 87% of the papers, exceeds unsupervised learning (12%). Within supervised learning, 64% of the papers dealt with classification issues and exceeds the regression methods (36%). Time-series were used in 61% of the papers and were mostly dealing with animal-based farm data. Multimedia data appeared in a greater number of recent papers. Based on these results, it can be concluded that Big Data is a relevant topic of research within the precision dairy farming area, but that the full potential of Big Data in this precision dairy farming area is not utilised yet. However, the present authors expect the full potential of Big Data, within the precision dairy farming area, will be reached when multiple Big Data characteristics (Volume, Variety and other V's) and sources (animal, groups, farms and chain parts) are used simultaneously, adding value to operational and strategic decision.
| S-EPMC6581964 | biostudies-literature
Project description:BackgroundMany new biomedical research articles are published every day, accumulating rich information, such as genetic variants, genes, diseases, and treatments. Rapid yet accurate text mining on large-scale scientific literature can discover novel knowledge to better understand human diseases and to improve the quality of disease diagnosis, prevention, and treatment.ResultsIn this study, we designed and developed an efficient text mining framework called SparkText on a Big Data infrastructure, which is composed of Apache Spark data streaming and machine learning methods, combined with a Cassandra NoSQL database. To demonstrate its performance for classifying cancer types, we extracted information (e.g., breast, prostate, and lung cancers) from tens of thousands of articles downloaded from PubMed, and then employed Naïve Bayes, Support Vector Machine (SVM), and Logistic Regression to build prediction models to mine the articles. The accuracy of predicting a cancer type by SVM using the 29,437 full-text articles was 93.81%. While competing text-mining tools took more than 11 hours, SparkText mined the dataset in approximately 6 minutes.ConclusionsThis study demonstrates the potential for mining large-scale scientific articles on a Big Data infrastructure, with real-time update from new articles published daily. SparkText can be extended to other areas of biomedical research.
| S-EPMC5042555 | biostudies-literature
Project description:PurposeTo prepare for big data analyses on radiation therapy data, we developed Stature, a tool-supported approach for standardization of structure names in existing radiation therapy plans. We applied the widely endorsed nomenclature standard TG-263 as the mapping target and quantified the structure name inconsistency in 2 real-world data sets.Methods and materialsThe clinically relevant structures in the radiation therapy plans were identified by reference to randomized controlled trials. The Stature approach was used by clinicians to identify the synonyms for each relevant structure, which was then mapped to the corresponding TG-263 name. We applied Stature to standardize the structure names for 654 patients with prostate cancer (PCa) and 224 patients with head and neck squamous cell carcinoma (HNSCC) who received curative radiation therapy at our institution between 2007 and 2017. The accuracy of the Stature process was manually validated in a random sample from each cohort. For the HNSCC cohort we measured the resource requirements for Stature, and for the PCa cohort we demonstrated its impact on an example clinical analytics scenario.ResultsAll but 1 synonym group ("Hydrogel") was mapped to the corresponding TG-263 name, resulting in a TG-263 relabel rate of 99% (8837 of 8925 structures). For the PCa cohort, Stature matched a total of 5969 structures. Of these, 5682 structures were exact matches (ie, following local naming convention), 284 were matched via a synonym, and 3 required manual matching. This original radiation therapy structure names therefore had a naming inconsistency rate of 4.81%. For the HNSCC cohort, Stature mapped a total of 2956 structures (2638 exact, 304 synonym, 14 manual; 10.76% inconsistency rate) and required 7.5 clinician hours. The clinician hours required were one-fifth of those that would be required for manual relabeling. The accuracy of Stature was 99.97% (PCa) and 99.61% (HNSCC).ConclusionsThe Stature approach was highly accurate and had significant resource efficiencies compared with manual curation.
| S-EPMC6349627 | biostudies-literature
Project description:Pediatric cancers rarely exhibit recurrent mutational events when compared to most adult cancers. This poses a challenge in understanding how cancers initiate, progress, and metastasize in early childhood. Also, due to limited detected driver mutations, it is difficult to benchmark key genes for drug development. In this review, we use neuroblastoma, a pediatric solid tumor of neural crest origin, as a paradigm for exploring "big data" applications in pediatric oncology. Computational strategies derived from big data science-network- and machine learning-based modeling and drug repositioning-hold the promise of shedding new light on the molecular mechanisms driving neuroblastoma pathogenesis and identifying potential therapeutics to combat this devastating disease. These strategies integrate robust data input, from genomic and transcriptomic studies, clinical data, and in vivo and in vitro experimental models specific to neuroblastoma and other types of cancers that closely mimic its biological characteristics. We discuss contexts in which "big data" and computational approaches, especially network-based modeling, may advance neuroblastoma research, describe currently available data and resources, and propose future models of strategic data collection and analyses for neuroblastoma and other related diseases.
| S-EPMC5297672 | biostudies-literature
Project description:The ubiquity and cheapness of miniature low-power sensors, digital processing, and large amounts of storage contained in small packages has heralded the ability to acquire large amounts of data about systems during their course of operation. The size and complexity of the data sets so generated have colloquially been labeled "big data." The computer science field of "data mining" has arisen with the purpose of extracting meaning from such data, expressly looking for patterns that not only link historic observations but also predict future behavior. This overview article considers the process, techniques, and interpretation of data mining, with specific focus on its application in audiology. Modern hearing instruments contain data-logging technology to record data separate from the audio stream, such as the acoustic environments in which the device was being used and how the signal processing was consequently operating. Combined with details about the patient, such as the audiogram, the variety of data generated lends itself to a data mining approach. To date, reports of the use and interpretation of these data have been mostly constrained to questions such as looking for changes in patterns of daily use, or the degree and direction of volume control manipulation as the patient's experience with a hearing aid changes. In this, and an accompanying results paper, the practical applications of some data mining techniques are described as applied to a large data set of examples of real-world device usage, as supplied by a hearing aid manufacturer.
| S-EPMC6022814 | biostudies-literature
Project description:The increasingly wide usage of smart infrastructure and location-aware terminals has helped increase the availability of trajectory data with rich spatiotemporal information. The development of data mining and analysis methods has allowed researchers to use these trajectory datasets to identify urban reality (e.g., citizens' collective behavior) in order to solve urban problems in transportation, environment, public security, etc. However, existing studies in this field have been relatively isolated, and an integrated and comprehensive review is lacking the problems that have been tackled, methods that have been tested, and services that have been generated from existing research. In this paper, we first discuss the relationships among the prevailing trajectory mining methods and then, classify the applications of trajectory data into three major groups: social dynamics, traffic dynamics, and operational dynamics. Finally, we briefly discuss the services that can be developed from studies in this field. Practical implications are also delivered for participants in trajectory data mining. With a focus on relevance and association, our review is aimed at inspiring researchers to identify gaps among tested methods and guiding data analysts and planners to select the most suitable methods for specific problems.
| S-EPMC7472055 | biostudies-literature
Project description:Pediatric cancer is a rare disease with a low annual incidence, which presents a significant challenge in being able to collect enough data to fuel clinical discoveries. Big data registry trials hold promise to advance the study of pediatric cancers by allowing for the combination of traditional randomized controlled trials with the power of larger cohort sizes. The emergence of big data resources and data-sharing initiatives are becoming transformative for pediatric cancer diagnosis and treatment. This review discusses the uses of big data in pediatric cancer, existing pediatric cancer registry initiatives and research, the challenges in harmonizing these data to improve accessibility for study, and building pediatric data commons and other important future endeavors.
| S-EPMC9036548 | biostudies-literature
Project description:Drug adverse events (AEs) are a major health threat to patients seeking medical treatment and a significant barrier in drug discovery and development. AEs are now required to be submitted during clinical trials and can be extracted from ClinicalTrials.gov ( https://clinicaltrials.gov/ ), a database of clinical studies around the world. By extracting drug and AE information from ClinicalTrials.gov and structuring it into a database, drug-AEs could be established for future drug development and repositioning. To our knowledge, current AE databases contain mainly U.S. Food and Drug Administration (FDA)-approved drugs. However, our database contains both FDA-approved and experimental compounds extracted from ClinicalTrials.gov . Our database contains 8,161 clinical trials of 3,102,675 patients and 713,103 reported AEs. We extracted the information from ClinicalTrials.gov using a set of python scripts, and then used regular expressions and a drug dictionary to process and structure relevant information into a relational database. We performed data mining and pattern analysis of drug-AEs in our database. Our database can serve as a tool to assist researchers to discover drug-AE relationships for developing, repositioning, and repurposing drugs.
| S-EPMC5175440 | biostudies-literature
Project description:In vitro bioassays have been developed and are currently being evaluated as potential alternatives to traditional animal toxicity models. Already, the progress of high throughput screening techniques has resulted in an enormous amount of publicly available bioassay data having been generated for a large collection of compounds. When a compound is tested using a collection of various bioassays, all the testing results can be considered as providing a unique bio-profile for this compound, which records the responses induced when the compound interacts with different cellular systems or biological targets. Profiling compounds of environmental or pharmaceutical interest using useful toxicity bioassay data is a promising method to study complex animal toxicity. In this study, we developed an automatic virtual profiling tool to evaluate potential animal toxicants. First, we automatically acquired all PubChem bioassay data for a set of 4,841 compounds with publicly available rat acute toxicity results. Next, we developed a scoring system to evaluate the relevance between these extracted bioassays and animal acute toxicity. Finally, the top ranked bioassays were selected to profile the compounds of interest. The resulting response profiles proved to be useful to prioritize untested compounds for their animal toxicity potentials and form a potential in vitro toxicity testing panel. The protocol developed in this study could be combined with structure-activity approaches and used to explore additional publicly available bioassay datasets for modeling a broader range of animal toxicities.
| S-EPMC4064997 | biostudies-literature